Cover Image

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Sebastiaan De Keersmaecker, Steffi De Meyer, Rik Vandenberghe
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non‐amnestic, mild cognitive impairment
by: Luwen Cao, et al.
Published: (2024)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
by: Steffi De Meyer, et al.
Published: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
by: Kevin Duff, et al.
Published: (2024)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
by: Jacqueline Chua, et al.
Published: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
by: Sunu Mathew, et al.
Published: (2025)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
by: Marieclaire Overton, et al.
Published: (2025)

Risk prediction of mild cognitive impairment using electronic health record data
by: Gang Li, et al.
Published: (2025)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
by: Rachel R. Jin, et al.
Published: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
by: María A. Rodríguez‐Santiago, et al.
Published: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
by: Juliana N. Souza‐Talarico, et al.
Published: (2025)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
by: Gustavo Luis Verón, et al.
Published: (2025)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
by: Julius Opwonya, et al.
Published: (2024)

Prevalence and predictors of diagnosed mild cognitive impairment among Medicare beneficiaries
by: Elyse Couch, et al.
Published: (2025)

The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
by: Simone Salemme, et al.
Published: (2025)

Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
by: Jessie T. Yan, et al.
Published: (2025)

Correction to “The prognosis of mild cognitive impairment: A systematic review and meta‐analysis”
Published: (2025)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
by: Adam H. Dyer, et al.
Published: (2025)

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
by: Kay Jann, et al.
Published: (2025)

The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
by: Craig Ritchie, et al.
Published: (2025)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
by: Yuhan Xie, et al.
Published: (2025)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
by: Ihab Hajjar, et al.
Published: (2024)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
by: Miguel Ángel Rivas‐Fernández, et al.
Published: (2026)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies
by: Paul C. Donaghy, et al.
Published: (2026)

The classification of mild cognitive impairment or healthy ageing improves when including practice effects derived from a semantic verbal fluency task
by: Felix Dörr, et al.
Published: (2025)

Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss
by: Vicente Medel, et al.
Published: (2024)

Cognitive dispersion is related to subtle objective daily functioning changes in older adults with and without cognitive impairment
by: Alyssa N. De Vito, et al.
Published: (2024)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
by: Lars Frings, et al.
Published: (2025)

Sex‐ and age‐specific effect of known type 2 diabetes mellitus on incident mild cognitive impairment five years later: Results from the population‐based Heinz Nixdorf Recall study
by: Anna Lena Platzbecker, et al.
Published: (2025)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
by: Zheng Long Lee, et al.
Published: (2026)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
by: Russell Banks, et al.
Published: (2024)

Midlife sensory and motor functions improve long‐term predictions of cognitive decline and incidence of cognitive impairment
by: Carla R. Schubert, et al.
Published: (2024)

Artificial intelligence detection of cognitive impairment in older adults during walking
by: Shuichi P. Obuchi, et al.
Published: (2024)

Modeling contributions of cognition and apathy to functional impairment in younger‐onset dementia
by: Samuel L. Warren, et al.
Published: (2026)

Neurofilament light chain concentration mediates the association between regional medial temporal lobe structure and memory in adults with Down syndrome
by: Natalie DiProspero, et al.
Published: (2024)

Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
by: Hankyung Jun, et al.
Published: (2026)

Feasibility of assessing cognitive impairment via distributed camera network and privacy‐preserving edge computing
by: Chaitra Hegde, et al.
Published: (2025)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
by: Sofia Toniolo, et al.
Published: (2024)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
by: Alisa Bannerjee, et al.
Published: (2025)

Human and large language model judgments of cognitive impairment from language: An explainable artificial intelligence approach
by: Maya Zadok, et al.
Published: (2026)

Association of apolipoprotein E genotype with cognitive performance: findings from the University of California, Davis Alzheimer's Disease Research Center longitudinal diversity cohort
by: Eva Min, et al.
Published: (2026)